Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: CAPLIPOINT and BSE: 524742 (ISIN INE475E01026).
It has a market capitalisation of ₹17,167 crore, a last close of ₹2,259 on 2026-10-19, a one-year return of 13.6%.
Valuation: a price-to-earnings ratio of 25.80x, a price-to-book ratio of 4.79x, a dividend yield of 0.4%.
Profitability: return on equity of 19.9%, return on capital employed of 24.5%, an operating margin of 34.8%.
Growth: sales growth of 14.2% a year over three years, net profit growth of 19.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 70.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 17,167 |
| Last close | ₹2,259 |
| P/E (TTM) | 25.80x |
| P/B | 4.79x |
| Dividend yield | 0.4% |
| ROE (FY) | 19.9% |
| ROCE (FY) | 24.5% |
| Operating margin (TTM) | 34.8% |
| Sales growth, 3-year CAGR | 14.2% |
| Profit growth, 3-year CAGR | 19.4% |
| Debt / equity | 0.00x |
| Promoter holding | 70.6% |
| 1-year return | 13.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means